Allistair Booth

IAM Research

The Patent 1000 focuses exclusively on patent practice and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.

Recommended - Individuals: transactions

“Thorough, organised, commercially sound and great at developing relationships with foreign counsel”, Pinsent Masons “acts as an extension of an in-house legal team”. The patent professionals across its European office network work hand in glove to meet and exceed the demands of its discerning clientele. Pharmaceuticals and biotechnology industries are happy hunting grounds, and generics leader Teva is a key client of note: cases which look set to make a splash include a Supreme Court spat with Eli Lilly/ICOS Corp; an SPC-related revocation dispute against Gilead and three other defendants in the CJEU; and a high-stakes damages claim against Warner-Lambert and Pfizer alongside a league of other claimants. Acting on all three is Charlotte Weekes, an internationally minded warrior with keen commercial acumen. IP and life sciences head Clare Tunstall – dubbed “the queen of the generic revocation case” – leads the charge against Gilead: “Her experience in the field is unparalleled and she is fantastic to work with.” Teva also receives vital support from Christopher Sharp, who has elsewhere prevailed for Accord Healthcare in revocation proceedings against Allergan Inc; he is “an excellent leader who is clear and decisive in his advice”. Another hotshot life sciences litigator is Nicole Jadeja, who gave the group a boost when she came on board in late 2019. She can walk in her clients’ shoes, having previously worked at a pharmaceutical multinational in a scientific capacity. On the transactional end, Allistair Booth has been getting a wide range of licensing and R&D agreements inked for the likes of RedX Pharma, 4D Pharma, and Evgen Pharma.

Get unlimited access to all IAM content